Formulation and Drug Delivery, Parenterals

FDA Approves GSK’s Treatment for Chronic Rhinosinusitis with Nasal Polyps

August 02, 2021

GSK announced that FDA has approved a new indication for Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5.

AstraZeneca’s Extensive-Stage Small Cell Lung Cancer Treatment Approved in China

July 20, 2021

In combination with etoposide and either carboplatin or cisplatin, Imfinzi has been approved in the first-line setting of ES-SCLC by China’s National Medical Products Administration.

BD to Invest $1.2 Billion Over Four Years in Pre-Fillable Syringe Manufacturing Capacity

December 02, 2020

The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe.

Factoring Stability in the Biologic Drug Mix

October 03, 2020

Excipients must be carefully chosen to ensure optimum protection for vaccines and live biotherapeutic products.

Evonik Qualifies Filling Line for Parenteral Drug Products at its Alabama Facility

September 09, 2020

The new line has the ability to aseptically fill powder, liquid, suspension, and combination forms into vials in clinical or commercial batch sizes.

Grand River Aseptic Manufacturing Opens Large-Scale Injectable Fill/Finish Facility

July 02, 2020

The new facility in Grand Rapids, MI, is part of the CDMO’s aggressive expansion plan.

Approaches to Alleviating Subcutaneous Injection-Site Pain for Citrate Formulations

June 02, 2020

The authors compare formulations containing citrate with other buffers in reducing subcutaneous injection-site pain and discuss a formulation and excipients selection strategy.

PharmTech Sponsored eBooks